© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
What’s next for sacral neuromodulation in OAB patients with Parkinson’s disease?
“I think the take home message is not to take sacral neuromodulation off the table,” says Sarah Martin, DO.
In this video, Sarah Martin, DO, discusses the take-home message from the recent Neurourology & Urodynamics study, “Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review,” for which she served as first author. Martin is an FPMRS fellow at Glickman Urological & Kidney Institute at Cleveland Clinic.
